Peter Heerma

Companies

• Travere Therapeutics, Inc.Chief Commercial Officer Oct 2, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX117,066 shares²$6.2M at $53.15Sep 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 17, 2026Sold 8,282 shares at $65.07 of Travere Therapeutics, Inc.²
• Sep 17, 2026Exercised options 8,282 shares at $22.40 of Travere Therapeutics, Inc.²
• Sep 16, 2026Sold 79,113 shares at $63.65 of Travere Therapeutics, Inc.²
• Sep 16, 2026Sold 93,604 shares at $63.25 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 17,717 shares at $26.88 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 55,000 shares at $15.46 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 100,000 shares at $11.25 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 1,431 shares at $65.31 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 1,400 shares at $63.65 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 27,421 shares at $62.59 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 71,938 shares at $62.05 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 36,526 shares at $8.93 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 1,381 shares at $22.40 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 39,283 shares at $26.88 of Travere Therapeutics, Inc.²
• May 5, 2026Sold 2,174 shares at $46.65 of Travere Therapeutics, Inc.³
• May 4, 2026Exercised options 4,250 shares of Travere Therapeutics, Inc.³
• Apr 14, 2026Sold 7,215 shares at $41.93 of Travere Therapeutics, Inc.⁴
• Apr 13, 2026Granted 14,000 shares of Travere Therapeutics, Inc.⁴
• Feb 3, 2026Sold 7,310 shares at $32.12 of Travere Therapeutics, Inc.⁵
• Jan 31, 2026Granted 26,120 shares of Travere Therapeutics, Inc.⁵
• Dec 24, 2025Sold 4,980 shares at $40.00 of Travere Therapeutics, Inc.⁶
• Nov 3, 2025Gift 1,078 shares of Travere Therapeutics, Inc.⁷
• Oct 31, 2025Sold 5,591 shares at $35.00 of Travere Therapeutics, Inc.⁷
• Oct 28, 2025Sold 2,662 shares at $30.00 of Travere Therapeutics, Inc.⁸
• Sep 23, 2025Gift 891 shares of Travere Therapeutics, Inc.⁹